Screener
Recursion Pharmaceuticals, Inc. RXRX Business Segments — Operating Income (Loss)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
| Line item | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Research and development | 89,614 | 128,636 | 177,510 | 258,269 |
| General and administrative | 41,533 | 46,653 | 76,124 | 101,304 |
| Total operating costs and expenses | 142,638 | 195,450 | 277,615 | 401,563 |
| Loss from operations | (134,968) | (176,227) | (263,472) | (367,595) |
| Other income (loss), net | 3,962 | 4,330 | 10,359 | (6,947) |
| Loss before income tax benefit | (131,006) | (171,897) | (253,113) | (374,542) |
| Income tax benefit | 1 | — | 4,604 | 158 |
| Net loss | $(131,005) | $(171,897) | $(248,509) | $(374,384) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Recursion Pharmaceuticals, Inc.'s business segments — operating income (loss)?
- Recursion Pharmaceuticals, Inc. (RXRX) reported business segments — operating income (loss) of -$134.97M in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s business segments — operating income (loss) changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s business segments — operating income (loss) increased by 23.4% year-over-year, from -$176.23M to -$134.97M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s business segments — operating income (loss)?
- Over 3 years (2022 to 2025), Recursion Pharmaceuticals, Inc.'s business segments — operating income (loss) has grown at a 38.2% compound annual growth rate (CAGR), from -$245.73M to -$648.13M.
- What does business segments — operating income (loss) mean?
- Calculated as the segment's total revenue minus its direct operating expenses, representing the profitability of the business segment before interest and taxes. This is the primary measure of the segment's operational efficiency and its ability to generate value from its core activities.
Ask your AI about Recursion Pharmaceuticals, Inc.'s business segments — operating income (loss).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude